{
  "docId": "019de074-01e2-758c-9358-12040e004419",
  "docSlug": "a93b7129565926c7be538a038211eae0",
  "documentTitle": "Larimar Therapeutics | Results Presentation Deck | 15 slides",
  "authorId": "larimar-therapeutics",
  "authorName": "Larimar Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 15,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a comparison of protein structures to explain the mechanism of action for the therapeutic candidate.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-01e2-758c-9358-12040e004419/3",
  "deckHref": "/decks/019de074-01e2-758c-9358-12040e004419",
  "deckJsonHref": "/decks/019de074-01e2-758c-9358-12040e004419.json",
  "deckAnchorHref": "/decks/019de074-01e2-758c-9358-12040e004419#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.28,
        "w": 0.42,
        "x": 0.55,
        "y": 0.53
      },
      "kind": "diagram",
      "text": "Structure of CTI-1601",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4be5c6ba-5b26-43b7-a4dd-be2d4899e313",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.42,
        "x": 0.55,
        "y": 0.135
      },
      "kind": "diagram",
      "text": "Structure of Endogenous Frataxin",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1fa7485-223a-4275-937d-193ea7682ed6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.1,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7f4434a-d563-4be2-8c33-8a876f485bde",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.17,
        "y": 0.47
      },
      "kind": "list",
      "text": "There is no approved treatment for Friedreich's ataxia",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a31835a-4275-4a06-88df-523ef928b77c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.17,
        "y": 0.68
      },
      "kind": "list",
      "text": "CTI-1601, a recombinant fusion protein designed to deliver human frataxin into mitochondria, is in development as a frataxin replacement therapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c5667de-7a6f-4194-a33e-44728cd4a6d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.17,
        "y": 0.185
      },
      "kind": "list",
      "text": "Friedreich's ataxia, the most common inherited ataxia, results from a deficiency of the mitochondrial protein frataxin",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f99e7ff3-1fd1-44b7-b7f4-d1ccd71032a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.24,
        "x": 0.025,
        "y": 0.03
      },
      "kind": "title",
      "text": "Background",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c35621a-daa6-4905-aa1e-6e47c290a232",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "9b2424a6-9504-4c85-8fe4-cd485ba96c98",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Background on Friedreich’s",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "f2c3a6aa-123d-4489-8eeb-7976fad47638",
      "evidence": "Background and study objective",
      "position": 0,
      "objective": "What if we don’t address Friedreich’s?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}